Economics of Vaccines for COVID-19
Monday October 5, 2020
5:00 pm to 6:30 pm

This Zoom webinar is free. Register at:
https://us02web.zoom.us/meeting/register/tZUpdu6oqDItG9yhU_fH7ug8nen7y9eqYKtR. Maximum # of participants is 100.

Presenters:
Bhaven Sampat, Associate Professor, Department of Health Policy and Management, Columbia University and Research Associate, National Bureau of Economic Research (NBER)

Ali Moghtaderi, Assistant Professor, Milken Institute School of Public Health, George Washington University

Bhaven Sampat will discuss how research on vaccines and viruses at the National Institutes of Health has accelerated the progress towards an effective vaccine. Bhaven’s expertise on how public research is translated into private sector results will help us understand the roots of ongoing efforts by companies, such as Moderna, Astra Zeneca, Merck, Johnson and Johnson, and Pfizer. He has published several articles on how public R&D investment affects private patenting and related topics in Review of Economic Studies, Science, and the American Economic Review

Ali Moghtaderi will discuss issues related to public acceptance of a vaccine, once an effective vaccine has been developed. Ali’s expertise in vaccines, especially Americans’ perspectives on taking the coronavirus vaccine, will help us understand reasons Americans have for not participating. He has published several articles on the economics of vaccines and other health economics topics in Health Affairs, JAMA, and Medical Care.

Leo Sveikauskas, economist at U.S. Bureau of Labor Statistics, will moderate this discussion.

Q&A will take place after the presentations.

Tags: